Advances in understanding of bile acid diarrhea

Expert Review of Gastroenterology and Hepatology

Volumn 8, Issue 1, 2014, Pages 49-61

  Camilleri, Michael ^a  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

Author keywords

ASBT; CDCA; colesevelam; DCA; FGF 19; FXR; IBAT; obeticholic acid; secretion; sequestrants

Indexed keywords

BILE ACID; CARBON 14; COLESEVELAM; COLESTYRAMINE; COMPLEMENT COMPONENT C4; DIPEPTIDYL PEPTIDASE IV INHIBITOR; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR 19; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLYCOCHOLIC ACID; METFORMIN; TAUROSELCHOLIC ACID SE 75;

BILE ACID DIARRHEA; BILE ACID MALABSORPTION; BILE ACID SYNTHESIS; CLINICAL PRACTICE; DIABETES MELLITUS; DIAGNOSTIC TEST; DIARRHEA; DIFFERENTIAL DIAGNOSIS; FECES LEVEL; HUMAN; ILEUM RESECTION; IRRITABLE COLON; ISOTOPE LABELING; MALABSORPTION; MICROBIOME; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; STOMACH EMPTYING;

ANTIDIARRHEALS; BILE ACIDS AND SALTS; DIARRHEA; FIBROBLAST GROWTH FACTORS; HUMANS; ILEUM; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84893080876     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2014.851599     Document Type: Review

References (98)

1. Hofmann AF, Small DM. Detergent properties of bile salts: Correlation with physiological function. Annu. Rev. Med. 18, 333-376 (1967
2. Rao AS, Wong B, Camilleri M et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: A pharmacodynamic and pharmacogenetic analysis. Gastroenterology 139, 1549-1558 (2010
3. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241-259 (2006
4. Hofmann AF. The syndrome of ileal disease and the broken enterohepatic circulation: Cholerhetic enteropathy. Gastroenterology 52, 752-757 (1967
5. Martinez-Augustin O, Sanchez de Medina F. Intestinal bile acid physiology and pathophysiology. World J. Gastroenterol. 14, 5630-5640 (2008
6. Halilbasic E, Claudel T, Trauner M. Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J. Hepatol. 58, 155-168 (2013
7. Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126, 322-342 (2004
8. Ballatori N, Li N, Fang F, Boyer JL, Christian WV, Hammond CL. OST alpha-OST beta: A key membrane transporter of bile acids and conjugated steroids. Front Biosci. (Landmark Ed). 14, 2829-2844 (2009
9. Wedlake L, A'Hern R, Russell D et al. Systematic Review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 30, 707-717 (2009
10. Mekhjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: Perfusion studies in man. J. Clin. Invest. 50, 1569-1577 (1971
11. Bampton PA, Dinning PG, Kennedy ML et al. The proximal colonic motor response to rectal mechanical and chemical stimulation. Am. J. Physiol. 282, G443-G449 (2002
12. Chadwick VS, Gaginella TS, Carlson GL et al. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J. Lab. Clin. Med. 94, 661-674 (1979
13. Hammer HF, Santa Ana CA, Schiller LR, Fordtran JS. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J. Clin. Invest. 84, 1056-1062 (1989
14. Conley DR, Coyne MJ, Bonorris GG, Chung A, Schoenfield LJ. Bile acid stimulation of colonic adenylate cyclase and secretion in the rabbit. Am. J. Dig. Dis. 21, 453-458 (1976
15. Alrefai WA, Saksena S, Tyagi S, Gill RK, Ramaswamy K, Dudeja PK. Taurodeoxycholate modulates apical Cl-/ OH-exchange activity in Caco2 cells. Dig. Dis. Sci. 52, 1270-1278 (2007
16. Ao M, Sarathy J, Domingue J, Alrefai WA, Rao MC. Chenodeoxycholic acid stimulates Cl-secretion via cAMP signaling and increases cystic fibrosis transmembrane conductance regulator phosphorylation in T84 cells. Am. J. Physiol. 305, C447-C456 (2013
17. Peregrin AT, Ahlman H, Jodal M, Lundgren O. Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin. Br. J. Pharmacol. 127, 887-894 (1999
18. Camilleri M, Murphy R. Chadwick VS. Pharmacological inhibition of chenodeoxycholic acid induced secretion of fluid and mucus in the rabbit colon. Dig. Dis. Sci. 27, 865 869 (1982
19. Yamada T, Inui A, Hayashi N, Fujimura M, Fujimiya M. Serotonin stimulates endotoxin translocation via 5-HT3 receptors in the rat ileum. Am. J. Physiol. 284, G782-G788 (2003
20. Kruis W, Haddad A, Phillips SF. Chenodeoxycholic and ursodeoxycholic acids alter motility and fluid transit in the canine ileum. Digestion 34, 185-195 (1986
21. Kirwan WO, Smith AN, Mitchell WD, Falconer JD, Eastwood MA. Bile acids and colonic motility in the rabbit and the human. Gut 16, 894-902 (1975
22. Hofmann AF, Poley Jr. Cholestyramine treatment of diarrhea associated with ileal resection. N. Engl. J. Med. 281, 397-402 (1969
23. Hofmann AF, Poley Jr. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology 62, 918-934 (1972
24. Poley JR, Hofmann AF. Role of fat maldigestion in pathogenesis of steatorrhea in ileal resection. Fat digestion after two sequential test meals with and without cholestyramine. Gastroenterology 71, 38-44 (1976
25. Williams AJ, Merrick MV, Eastwood MA. Idiopathic bile acid malabsorption-A review of clinical presentation, diagnosis, and response to treatment. Gut 32, 1004-1006 (1991
26. Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br. Med. J. 290, 665-668 (1985
27. Fernández-Bañares F, Esteve M, Salas A et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am. J. Gastroenterol. 102, 2520-2528 (2007
28. Wildt S, Nørby Rasmussen S, Lysga°rd Madsen J, Rumessen JJ. Bile acid malabsorption in patients with chronic diarrhoea: Clinical value of SeHCAT test. Scand. J. Gastroenterol. 38, 826-830 (2003
29. Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol. Motil. 24, 983 e538 (2012
30. Limsui D, Pardi DS, Camilleri M et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm. Bowel Dis. 13, 175-181 (2007
31. Walters JR, Pattni SS. Managing bile acid diarrhoea. Ther. Adv. Gastroenterol. 3, 349-357 (2010
32. Bouchoucha M, Uzzan B, Cohen R. Metformin and digestive disorders. Diabetes Metab. 37, 90-96 (2011
33. Caspary WF, Zavada I, Reimold W, Deuticke U, Emrich D, Willms B. Alteration of bile acid metabolism and vitamin-B12-Absorption in diabetics on biguanides. Diabetologia 13, 187-193 (1977
34. Scarpello JH, Hodgson E, Howlett HC. Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus. Diabet. Med. 15, 651-656 (1998
35. Bjarnason I, Sharpstone DR, Francis N et al. Intestinal inflammation, ileal structure and function in HIV. AIDS 10, 1385-1391 (1996
36. Lundasen T, Galman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J. Intern. Med. 260, 530-536 (2006
37. Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, Le Roux CW. A new mechanism for bile acid diarrhea: Defective feedback inhibition of bile acid biosynthesis. Clin. Gastroenterol. Hepatol. 7, 1189-1194 (2009
38. Montagnani M, Love MW, Rössel P, Dawson PA, Qvist P. Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption. Scand. J. Gastroenterol. 36, 1077-1080 (2001
39. Montagnani M, Abrahamsson A, Gälman C et al. Analysis of ileal sodium/ bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption. World J. Gastroenterol. 12, 7710-7714 (2006
40. Sciarretta G, Fagioli G, Furno A et al. 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 28, 970-975 (1987
41. Sadik R, Abrahamsson H, Ung KA, Stotzer PO. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am. J. Gastroenterol. 99, 711-718 (2004
42. Valdés Olmos R, den Hartog Jager F, Hoefnagel C, Taal B. Effect of loperamide and delay of bowel motility on bile acid malabsorption caused by late radiation damage and ileal resection. Eur J Nucl. Med. 18, 346-350 (1991
43. Yeoh EK, Horowitz M, Russo A, Muecke T, Robb T, Chatterton BE. Gastrointestinal function in chronic radiation enteritis-effects of loperamide-N-oxide. Gut 34, 476-482 (1993
44. Bajor A, Kilander A, Fae A et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur. J. Gastroenterol. Hepatol. 8, 397-403 (2006
45. Bajor A, Gillberg PG, Abrahamsson H. Bile acids: Short and long term effects in the intestine. Scand. J. Gastroenterol. 45, 645-664 (2010
46. Wong BS, Camilleri M, Carlson PJ et al. A klothob variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology 140, 1934-1942 (2011
47. Kawamata Y, Fujii R, Hosoya M et al. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278, 9435-9440 (2003
48. Ward JB, Mroz MS, Keely SJ. The bile acid receptor, TGR5, regulates basal and cholinergic-induced secretory responses in rat colon. Neurogastroenterol. Motil. 25, 708-711 (2013
49. Poole DP, Godfrey C, Cattaruzza F et al. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol. Motil. 22, 814-25 (2010
50. Hov JR, Keitel V, Laerdahl JK et al. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS ONE 5, e12403 (2010
51. Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E, Baldelli F. Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr. Mol. Med. 10, 579-595 (2010
52. Camilleri M, Vazquez-Roque MI, Carlson P, Burton D, Wong BS, Zinsmeister AR. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders. Neurogastroenterol. Motil. 23, 995-999, 458 (2011
53. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N. Engl. J. Med. 367, 1626-1635 (2012
54. Galatola G, Jazrawi RP, Bridges C, Joseph AE, Northfield TC. Direct measurement of first-pass ileal clearance of a bile acid in humans. Gastroenterology 100, 1100-1105 (1991
55. van Tilburg AJ, de Rooij FW, van den Berg JW, Kooij PP, van Blankenstein M. The selenium-75-homocholic acid taurine test re-evaluated: Combined measurement of fecal selenium-75 activity and 3 alpha-hydroxy bile acids in 211 patients. J. Nucl. Med. 32, 1219-1224 (1991
56. Sciarretta G, Furno A, Mazzoni M, Malaguti P. Post-cholecystectomy diarrhea: Evidence of bile acid malabsorption assessed by SeHCAT test. Am. J. Gastroenterol. 87, 1852-1854 (1992
57. Suhr O, Danielsson A, Nyhlin H, Truedsson H. Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand. J. Gastroenterol. 23, 1187-1194 (1988
58. Kurien M, Evans KE, Leeds JS, Hopper AD, Harris A, Sanders DS. Bile acid malabsorption: An under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scand. J. Gastroenterol. 46, 818-822 (2011
59. Al-Hadrani A, Lavelle-Jones M, Kennedy N, Neill G, Sutton D, Cuschieri A. Bile acid malabsorption in patients with postvagotomy diarrhoea. Ann. Chir. Gynaecol. 81, 351-353 (1992
60. Ladas SD, Isaacs PE, Quereshi Y, Sladen G. Role of the small intestine in postvagotomy diarrhea. Gastroenterology 85, 1088-1093 (1983
61. Fort JM, Azpiroz F, Casellas F, Andreu J, Malagelada Jr. Bowel habit after cholecystectomy: Physiological changes and clinical implications. Gastroenterology 111, 617-622 (1996
62. Phillips SF. Diarrhea after cholecystectomy: If so, why? Gastroenterology 111, 816-818 (1996
63. Bisschop PH, Bandsma RH, Stellaard F et al. Low-fat, high-carbohydrate and high-fat, low-carbohydrate diets decrease primary bile acid synthesis in humans. Am. J. Clin. Nutr. 79, 570-576 (2004
64. Li T, Matozel M, Boehme S et al. Overexpression of cholesterol 7a-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology 53, 996-1006 (2001
65. Jonkers IJ, Smelt AH, Princen HM et al. Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia. J. Nutr. 136, 987-991 (2006
66. Devkota S, Wang Y, Musch MW et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 487, 104-108 (2012
67. Laue H, Denger K, Cook AM. Taurine reduction in anaerobic respiration of Bilophila wadsworthia RZATAU Appl. Environ. Microbiol. 63, 2016-2021 (1997
68. Lindstedt S, Avigan J, Goodman DS, Sjövall J, Steinberg DJ. The effect of dietary fat on the turnover of cholic acid and on the composition of the biliary bile acids in man. Clin. Invest. 44, 1754-1765 (1965
69. Scarpello JH, Hodgson E, Howlett HC. Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus. Diabet. Med. 15, 651-656 (1998
70. Caspary WF, Zavada I, Reimold W, Deuticke U, Emrich D, Willms B. Alteration of bile acid metabolism and vitamin-B12-Absorption in diabetics on biguanides. Diabetologia 13, 187-193 (1977
71. Sayin SI, Wahlström A, Felin J et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225-235 (2013
72. Zhao Y, Wu J, Li JV, Zhou NY, Tang H, Wang Y. Gut microbiota composition modifies fecal metabolic profiles in mice. J. Proteome Res. 12, 2987-2999 (2013
73. Ridlon JM, Alves JM, Hylemon PB, Bajaj JS. Cirrhosis, bile acids, and gut microbiota: Unraveling a complex relationship. Gut Microbes 4(5) (2013
74. Ou J, Carbonero F, Zoetendal EG et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J. Clin. Nutr. 98, 111-120 (2013
75. Duboc H, Rajca S, Rainteau D et al. Connecting dysbiosis, bile-Acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62, 531-539 (2013
76. Duboc H, Rainteau D, Rajca S et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24, 513-520 (2012
77. Kakiyama G, Pandak WM, Gillevet PM et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J. Hepatol. 58, 949-955 (2013
78. Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and non-Alcoholic fatty liver disease: New insights. Clin. Microbiol. Infect. 19, 338-348 (2013
79. Ridaura VK, Faith JJ, Rey FE et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013
80. Camilleri M. Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? The con argument. Clin. Gastroenterol. Hepatol. 8, 129-132 (2010
81. Surowiec D, Kuyumjian AG, Wynd MA et al. Past, present, and future therapies for Clostridium difficile-Associated disease. Ann. Pharmacother. 40, 2155-2163 (2006
82. Weiss K. Toxin-binding treatment for Clostridium difficile: A review including reports of studies with tolevamer. Int. J. Antimicrob. Agents 33, 4-7 (2009
83. Vijayvargiya P, Camilleri M, Shin A, Saenger A. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin. Gastroenterol. Hepatol. 11(10), 1232-1239 (2013
84. Wong BS, Camilleri M, Carlson P et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin. Gastroenterol. Hepatol. 10, 1009-1015 (2012
85. Shin A, Camilleri M, Vijayvargiya P et al. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 11(10), 1270-1275 e1 (2013
86. Pattni SS, Brydon WG, Dew T, Walters Jr. Fibroblast growth factor 19 and 7a-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea. Clin. Transl. Gastroenterol. 3, e18 (2012
87. Pattni SS, Brydon WG, Dew T et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: A prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment. Pharmacol. Ther. 38(8), 967-976 (2013
88. Camilleri M, Acosta A. Invited commentary: Fibroblast growth factor 19 in patients with bile acid diarrhea: A prospective comparison of FGF19 serum assay and SeHCAT retention by Pattni et al. Aliment. Pharmacol. Ther. (In press
89. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin. Gastroenterol. Hepatol. 8, 159-165 (2010
90. Wong BS, Camilleri M, Carlson PJ et al. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig. Dis. Sci. 57, 1222-1226 (2012
91. Zhang JH, Nolan JD, Kennie SL et al. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Am. J. Physiol. 304, G940-G948 (2013
92. Johnston IM, Nolan JD, Dew T, Shapiro D, Walters JRF. A new therapy for chronic diarrheä A proof of concept study of the FXR agonist obeticholic acid in patients with primary bile acid diarrhea. Gastroenterology 144(Suppl. 144), S60 (2013
93. Keating N, Mroz MS, Scharl MM et al. Physiological concentrations of bile acids down-regulate agonist induced secretion in colonic epithelial cells. J. Cell Mol. Med. 13, 2293-2303 (2009
94. Mroz MS, Keating N, Ward J, et al. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo. Gut doi:10.1136/gutjnl-2013-305088 (2013) (Epub ahead of print
95. Nolan JD, Johnston IM, Walters Jr. Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: A new perspective. Expert Rev. Gastroenterol. Hepatol. 7, 49-56 (2013
96. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: A meta-Analysis. Clin. Gastroenterol. Hepatol. 10, 712-721 (2012
97. Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: Systematic review and meta-Analysis. Am. J. Gastroenterol. 107, 991-1000 (2012
98. Omar MI, Alexander CE. Drug treatment for faecal incontinence in adults. Cochrane Database Syst. Rev. (6), CD002116 (2013